Skip to content
Life Sciences Series A Founded 2014

DAMAE Medical

Developer of imaging diagnostic device for skin cancer

📍 Paris, France · Oncology

Funding snapshot

Last roundSeries A
Amount$7M
Date3 February 2022

About

Developer of imaging diagnostic device for skin cancer. The deepLive medical device is based on line-field confocal optical coherence tomography technology which provides a unique 3D imaging of multiple skin conditions and non-invasive diagnosis of skin cancers.

Latest news

No articles yet.

Raising like DAMAE Medical?

Analyze your pitch deck before your next raise.

Analyze My Deck →